Filing Flows › Maravai Lifesciences Holdings (MRVI) › Who owns the stock
Who owns Maravai Lifesciences Holdings (MRVI) stock
168 funds reported Maravai Lifesciences Holdings (MRVI) shares in their latest 13F filings, worth $791M in all. The largest holder is Gtcr LLC ($126M). Last quarter 88 funds added to their stakes and 69 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Gtcr LLC | 20,150,005 | $126M | unchanged | 2026-06-30 |
| BlackRock | 9,970,780 | $62.2M | increase | 2026-06-30 |
| First Eagle Investment Management, LLC | 7,342,574 | $45.8M | increase | 2026-06-30 |
| 12 West Capital Management LP | 7,060,195 | $44.1M | decrease | 2026-06-30 |
| Millennium Management LLC | 6,508,220 | $40.6M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 5,283,665 | $33.0M | decrease | 2026-06-30 |
| Renaissance Technologies LLC | 4,606,491 | $28.7M | increase | 2026-06-30 |
| Vanguard Group | 7,166,528 | $23.3M | increase | 2025-12-31 |
| Geode Capital Management, LLC | 3,130,258 | $19.5M | increase | 2026-06-30 |
| State Street | 2,901,706 | $18.1M | increase | 2026-06-30 |
| Nuveen, LLC | 2,857,580 | $17.8M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 2,255,820 | $14.1M | increase | 2026-06-30 |
| Monaco Asset Management SAM | 2,231,026 | $13.9M | decrease | 2026-06-30 |
| Prudential Financial | 2,152,154 | $13.4M | increase | 2026-06-30 |
| Citadel Advisors LLC | 2,122,598 | $13.2M | increase | 2026-06-30 |
Maravai Lifesciences Holdings' latest quarter
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most MRVI stock?
By the latest 13F filings: Gtcr LLC ($126M); BlackRock ($62.2M); First Eagle Investment Management, LLC ($45.8M); 12 West Capital Management LP ($44.1M); Millennium Management LLC ($40.6M).
What is the short interest in MRVI?
13,348,935 shares were sold short at the 2026-10-15 settlement, -3.45% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.